Amsterdam’s Avidicure exits stealth mode with €43.8M to develop new antibody therapies
Based out of Amsterdam, Avidicure, a biotechnology company, announced its launch with $50M (approximately €43.8M) in a seed financing round ...
Friday, July 18, 2025
Tag: antibody
The first and only national digital and print magazine that connects individuals, families, and businesses to Fee-Only financial advisers, accountants, attorneys and college guidance counselors.